Platelet–monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with αIIbβ3 and αMβ2, in coronary stenting
Laura L. Fernandes(United States Food and Drug Administration), Neal S. Kleiman(Houston Methodist), Nelson Bennet(Baylor College of Medicine), Larry V. McIntire(Freeman Health System), Christie M. Ballantyne(Baylor College of Medicine), Ian Del Conde(Baylor College of Medicine), Jeffrey A. Klem(Baylor College of Medicine), Shiba Mathew(Baylor College of Medicine), Nikolaos G. Frangogiannis(Albert Einstein College of Medicine), C. Wayne Smith(Baylor College of Medicine), E. O’Brian Smith(Children's Nutrition Research Center at Baylor College of Medicine), Nancy A. Turner(Baylor College of Medicine), Kelley J Maresh(Baylor College of Medicine), Karen R. Snapp(Baylor College of Medicine), Geoffrey S. Kansas(Northwestern University)
Cited by 45
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k